Cargando…

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease

BACKGROUND: Tumor necrosis factor-alpha inhibitors, including infliximab and adalimumab, are effective medical treatments for perianal fistulising Crohn’s disease (CD), but not all patients achieve fistula healing. AIM: To determine the correlation between perianal fistula healing and closure with i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Bonita, Venkatesh, Kavya, Williams, Astrid-Jane, Ng, Watson, Corte, Crispin, Gholamrezaei, Ali, Ghaly, Simon, Xuan, Wei, Paramsothy, Sudarshan, Connor, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254145/ https://www.ncbi.nlm.nih.gov/pubmed/35949350 http://dx.doi.org/10.3748/wjg.v28.i23.2597

Ejemplares similares

Diagnostic performance of texture analysis in the differential diagnosis of perianal fistulising Crohn’s disease and glandular anal fistula
por: Zhu, Xin, et al.
Publicado: (2023)

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
por: Im, Jong Pil
Publicado: (2017)

Prospective randomised controlled trial of adults with perianal fistulising Crohn’s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol
por: Gu, Bonita, et al.
Publicado: (2021)

Novel Approaches to Ileocolic and Perianal Fistulising Crohn's Disease
por: Luglio, Gaetano, et al.
Publicado: (2018)

Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort study
por: Zhu, Ping, et al.
Publicado: (2022)

Review of local injection of anti-TNF for perianal fistulising Crohn’s disease
por: Adegbola, Samuel O., et al.
Publicado: (2017)

Developing a core outcome set for fistulising perianal Crohn’s disease
por: Sahnan, Kapil, et al.
Publicado: (2019)

ANALYSIS OF THE CLINICAL CHARACTERISTICS OF PERIANAL FISTULISING CROHN’S DISEASE IN A SINGLE CENTER
por: XU, Min-Min, et al.
Publicado: (2019)

Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy
por: Cao, Wan-Ting, et al.
Publicado: (2022)

Patient and general population values for luminal and perianal fistulising Crohn’s disease health states
por: Rencz, Fanni, et al.
Publicado: (2019)

Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn’s Disease
por: Orts, Beatriz, et al.
Publicado: (2022)

Infliximab for Crohn’s Disease Patients with Perianal Fistulas: Better Image, Better Life
por: Hong, Liwen, et al.
Publicado: (2020)

Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
por: Lee, Jong Lyul
Publicado: (2019)

Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis
por: Godoy Brewer, Gala M, et al.
Publicado: (2021)

Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020)

Treatment of Perianal Crohn Disease Fistulae
por: Osterman, Mark T., et al.
Publicado: (2008)

MRI of perianal fistulas in Crohn’s disease
por: Reginelli, Alfonso, et al.
Publicado: (2020)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease
por: Jeon, Myunghoon, et al.
Publicado: (2019)

Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn’s Disease
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging
por: Yan, Xiaohan, et al.
Publicado: (2019)

Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity
por: Song, Christine H, et al.
Publicado: (2012)

Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
por: Ji, Cheng-Chun, et al.
Publicado: (2017)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn’s Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
por: Sorrentino, Dario, et al.
Publicado: (2015)

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)

Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study
por: Sirmai, Laura, et al.
Publicado: (2022)

Effectiveness of infliximab in the treatment of perianal fistulas in ulcerative colitis: report of two cases
por: de la Piscina, Patricia Ramírez, et al.
Publicado: (2013)

Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
por: Choi, So Yoon, et al.
Publicado: (2023)

Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn’s disease
por: Carlsen, Arne, et al.
Publicado: (2018)

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
por: Reinisch, Walter, et al.
Publicado: (2020)

Recent developments in the surgical management of perianal fistula for Crohn’s disease
por: Geltzeiler, Cristina B., et al.
Publicado: (2014)

Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas
por: Al-Maawali, Alghalya Khalid Sulaiman, et al.
Publicado: (2016)

Efficacy of Vedolizumab in Fistulising Crohn’s Disease: Exploratory Analyses of Data from GEMINI 2
por: Feagan, Brian G, et al.
Publicado: (2018)

A Meta-Analysis of Adalimumab for Fistula in Crohn's Disease
por: Fu, Yin-mei, et al.
Publicado: (2017)

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
por: Koga, Akihiro, et al.
Publicado: (2018)

Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn’s Disease: Results from IMAgINE 1 and IMAgINE 2
por: Ruemmele, Frank M, et al.
Publicado: (2018)

Corrigendum to: Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
Publicado: (2021)

Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review
por: Panes, Julian, et al.
Publicado: (2018)

Surgical treatment for cryptoglandular and Crohn’s perianal fistulas: Protocol of an umbrella review
por: Mei, Zubing, et al.
Publicado: (2021)

The Multidisciplinary Management of Perianal Fistulas in Crohn’s Disease: A Systematic Review
por: Badla, Omar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1i49mg6ld85cs891jkstlj84oi